Table 6.
Relationship of clinical stage with HOTAIR/HOTTIP polymorphisms in GC patients.
| Stage | |||
|---|---|---|---|
| I, II | III, IV | p-value | |
| rs17720428 | 0.23 | ||
| TT | 7 (7.6%) | 85 (92.4%) | |
| TG | 5 (3.7%) | 130 (96.3%) | |
| GG | 4 (10.3%) | 35 (89.7%) | |
| rs7958904 | 0.08 | ||
| GG | 6 (8.5%) | 65 (91.5%) | |
| GC | 4 (2.9%) | 132 (97.1%) | |
| CC | 6 (10.3%) | 52 (89.7%) | |
| rs1899663 | 0.23 | ||
| GG | 7 (7.6%) | 85 (92.4%) | |
| GT | 5 (3.7%) | 130 (96.3%) | |
| TT | 4 (10.3%) | 35 (89.7%) | |
| rs4759314 | 0.85 | ||
| AA | 15 (6%) | 237 (94%) | |
| AG | 1 (7.1%) | 13 (92.9%) | |
| rs3807598 | 0.98 | ||
| CC | 5 (6.2%) | 75 (93.8%) | |
| CG | 7 (5.7%) | 115 (94.3%) | |
| GG | 4 (6.3%) | 59 (93.7%) | |
| rs17501292 | 0.44 | ||
| TT | 9 (4.9%) | 176 (95.1%) | |
| TG | 6 (9.2%) | 59 (90.8%) | |
| GG | 1 (7.1%) | 13 (92.9%) | |
| rs1859168 | 0.41 | ||
| CC | 16 (6.7%) | 224 (93.3%) | |
| CA | 0 (0%) | 24 (100%) | |
| AA | 0 (0%) | 1 (100%) | |